New York City is doubling down on its long-discussed, never-realized dream of building a biotech hub to rival South San Francisco and Boston. The latest iteration of the dream comes backed by a $500 million financing package and a goal to quadruple the amount of R&D space in the city.
City officials sketched out the funding that is available as part of a request for proposals about how to increase the amount of life science space on the rental market.
